HNRNPC as a Pan-Cancer Biomarker and Therapeutic Target
Author Information
Author(s): ZHANG YUEZHOU, ZHANG ZHAO, DONG JINXIN, LIU CHANGAN
Primary Institution: The Second Affiliated Hospital of Chongqing Medical University
Hypothesis
HNRNPC plays a significant role in tumor progression and immune regulation across various cancers.
Conclusion
HNRNPC is identified as a prognostic marker in multiple cancers and is involved in shaping the tumor immune microenvironment.
Supporting Evidence
- HNRNPC is overexpressed in 20 out of 26 prevalent malignancies.
- HNRNPC levels are associated with reduced overall survival in multiple cancer types.
- Silencing HNRNPC inhibits liver cancer cell proliferation and metastasis.
- HNRNPC expression correlates with immune infiltration levels in various cancers.
- HNRNPC is linked to tumor mutation burden and microsatellite instability.
Takeaway
HNRNPC is a protein that helps cancer cells grow and hide from the immune system, and targeting it could help treat different types of cancer.
Methodology
The study utilized publicly available databases like TCGA and GTEx for pan-cancer analysis and performed experimental validation in liver cancer cell lines.
Limitations
The study did not conduct comprehensive transcriptomic and proteomic analyses.
Participant Demographics
The study analyzed data from various cancer types, including demographic characteristics like age and sex.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website